Editorial
doi: 10.1056/NEJMe1215043.
Anemia treatment in patients with chronic kidney disease
- PMID: 23343068
- DOI: 10.1056/NEJMe1215043
Item in Clipboard
Editorial
Anemia treatment in patients with chronic kidney disease
N Engl J Med.
.
No abstract available
Comment on
-
Peginesatide in patients with anemia undergoing hemodialysis.N Engl J Med. 2013 Jan 24;368(4):307-19. doi: 10.1056/NEJMoa1203165. N Engl J Med. 2013. PMID: 23343061 Clinical Trial.
-
Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.N Engl J Med. 2013 Jan 24;368(4):320-32. doi: 10.1056/NEJMoa1203166. N Engl J Med. 2013. PMID: 23343062 Clinical Trial.
Similar articles
-
On peginesatide and anemia treatment in CKD.Am J Kidney Dis. 2013 Oct;62(4):659-61. doi: 10.1053/j.ajkd.2013.05.008. Epub 2013 Jun 28. Am J Kidney Dis. 2013. PMID: 23810692 No abstract available.
-
Darbepoetin Alfa Versus Erythropoietin Alfa for Treatment of Renal Anemia in Patients with Chronic Kidney Disease at the Pre-Dialysis Stage: A Randomized Non-inferiority Trial.J Assoc Physicians India. 2019 Jan;67(1):62-66. J Assoc Physicians India. 2019. PMID: 30935177 Clinical Trial. No abstract available.
-
Possible role of neocytolysis in anemia in hemodialysis patients with darbepoetin alfa or continuous erythropoietin receptor activator.Ther Apher Dial. 2020 Oct;24(5):602-606. doi: 10.1111/1744-9987.13537. Epub 2020 Jul 28. Ther Apher Dial. 2020. PMID: 32537874 No abstract available.
-
[Pharmacological and clinical profiles of long-lasting erythropoiesis-stimulating agent (darbepoetin alfa; NESP].Nihon Yakurigaku Zasshi. 2008 Apr;131(4):291-9. doi: 10.1254/fpj.131.291. Nihon Yakurigaku Zasshi. 2008. PMID: 18408341 Review. Japanese. No abstract available.
-
Anemia in chronic kidney disease: causes, diagnosis, treatment.Cleve Clin J Med. 2006 Mar;73(3):289-97. doi: 10.3949/ccjm.73.3.289. Cleve Clin J Med. 2006. PMID: 16548452 Review.
Cited by
-
Association of red blood cell distribution width levels with severity of coronary artery disease in patients with non-ST elevation myocardial infarction.Med Princ Pract. 2015;24(2):178-83. doi: 10.1159/000369396. Epub 2014 Dec 16. Med Princ Pract. 2015. PMID: 25531370 Free PMC article.
-
Narrative Review of Hyperferritinemia, Iron Deficiency, and the Challenges of Managing Anemia in Aboriginal and Torres Strait Islander Australians With CKD.Kidney Int Rep. 2020 Nov 10;6(2):501-512. doi: 10.1016/j.ekir.2020.10.035. eCollection 2021 Feb. Kidney Int Rep. 2020. PMID: 33615076 Free PMC article. Review.
-
RHEX, a novel regulator of human erythroid progenitor cell expansion and erythroblast development.J Exp Med. 2014 Aug 25;211(9):1715-22. doi: 10.1084/jem.20130624. Epub 2014 Aug 4. J Exp Med. 2014. PMID: 25092874 Free PMC article.
-
Hypoxia-Inducible Factor-Proline Hydroxylase Inhibitor in the Treatment of Renal Anemia.Kidney Dis (Basel). 2021 Jan;7(1):1-9. doi: 10.1159/000510587. Epub 2020 Dec 17. Kidney Dis (Basel). 2021. PMID: 33614728 Free PMC article. Review.
-
Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients.PLoS One. 2016 Mar 3;11(3):e0148938. doi: 10.1371/journal.pone.0148938. eCollection 2016. PLoS One. 2016. PMID: 26939055 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
